Selected research
Market Outlook & Growth Opportunities
Global AI-powered X Ray Imaging Market Outlook and Growth Opportunities 2026
Market perspective
The global AI-powered X Ray Imaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for AI-powered X Ray Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for AI-powered X Ray Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI-powered X Ray Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the AI-powered X Ray Imaging market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the AI-powered X Ray Imaging market include GE Healthcare, Hologic, FUJIFILM Holdings, Siemens Healthineers AG, Nuance Communications, Lunit, Zebra Medical Vision, Arterys Inc and Qure.ai, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global AI-powered X Ray Imaging market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of AI-powered X Ray Imaging and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents AI-powered X Ray Imaging revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI-powered X Ray Imaging market.
AI-powered X Ray Imaging Segment by Company
GE Healthcare
Hologic
FUJIFILM Holdings
Siemens Healthineers AG
Nuance Communications
Lunit
Zebra Medical Vision
Arterys Inc
Qure.ai
Agfa-Gevaert Group
Riverain Technologies
Oxipit
DeepTek Medical Imaging Private Limited.
ICAD Inc
Behold.ai Technologies
Imagen Technologies
VUNO
AI-powered X Ray Imaging Segment by Type
Hardware
Software and Services
AI-powered X Ray Imaging Segment by Application
Hospitals
Diagnostic Centers
Others
AI-powered X Ray Imaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global AI-powered X Ray Imaging status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the AI-powered X Ray Imaging key companies, revenue, market share, and recent developments.
3. To split the AI-powered X Ray Imaging breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions AI-powered X Ray Imaging market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify AI-powered X Ray Imaging significant trends, drivers, influence factors in global and regions.
6. To analyze AI-powered X Ray Imaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-powered X Ray Imaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI-powered X Ray Imaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-powered X Ray Imaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI-powered X Ray Imaging industry.
Chapter 3: Detailed analysis of AI-powered X Ray Imaging company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of AI-powered X Ray Imaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of AI-powered X Ray Imaging in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Hardware
- Software and Services
Applications
- Hospitals
- Diagnostic Centers
- Others
Companies covered
- GE Healthcare
- Hologic
- FUJIFILM Holdings
- Siemens Healthineers AG
- Nuance Communications
- Lunit
- Zebra Medical Vision
- Arterys Inc
- Qure.ai
- Agfa-Gevaert Group
- Riverain Technologies
- Oxipit
- DeepTek Medical Imaging Private Limited.
- ICAD Inc
- Behold.ai Technologies
- Imagen Technologies
- VUNO
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global AI-powered X Ray Imaging Market Size, 2021 VS 2025 VS 2032
- 1.3 Global AI-powered X Ray Imaging Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 AI-powered X Ray Imaging Market Dynamics
- 2.1 AI-powered X Ray Imaging Industry Trends
- 2.2 AI-powered X Ray Imaging Industry Drivers
- 2.3 AI-powered X Ray Imaging Industry Opportunities and Challenges
- 2.4 AI-powered X Ray Imaging Industry Restraints
3 AI-powered X Ray Imaging Market by Company
- 3.1 Global AI-powered X Ray Imaging Company Revenue Ranking in 2025
- 3.2 Global AI-powered X Ray Imaging Revenue by Company (2021-2026)
- 3.3 Global AI-powered X Ray Imaging Company Ranking (2024-2026)
- 3.4 Global AI-powered X Ray Imaging Company Manufacturing Base and Headquarters
- 3.5 Global AI-powered X Ray Imaging Company Product Type and Application
- 3.6 Global AI-powered X Ray Imaging Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global AI-powered X Ray Imaging Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 AI-powered X Ray Imaging Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 AI-powered X Ray Imaging Market by Type
- 4.1 AI-powered X Ray Imaging Type Introduction
- 4.1.1 Hardware
- 4.1.2 Software and Services
- 4.2 Global AI-powered X Ray Imaging Sales Value by Type
- 4.2.1 Global AI-powered X Ray Imaging Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global AI-powered X Ray Imaging Sales Value by Type (2021-2032)
- 4.2.3 Global AI-powered X Ray Imaging Sales Value Share by Type (2021-2032)
5 AI-powered X Ray Imaging Market by Application
- 5.1 AI-powered X Ray Imaging Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Diagnostic Centers
- 5.1.3 Others
- 5.2 Global AI-powered X Ray Imaging Sales Value by Application
- 5.2.1 Global AI-powered X Ray Imaging Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global AI-powered X Ray Imaging Sales Value by Application (2021-2032)
- 5.2.3 Global AI-powered X Ray Imaging Sales Value Share by Application (2021-2032)
6 AI-powered X Ray Imaging Regional Value Analysis
- 6.1 Global AI-powered X Ray Imaging Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global AI-powered X Ray Imaging Sales Value by Region (2021-2032)
- 6.2.1 Global AI-powered X Ray Imaging Sales Value by Region: 2021-2026
- 6.2.2 Global AI-powered X Ray Imaging Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America AI-powered X Ray Imaging Sales Value (2021-2032)
- 6.3.2 North America AI-powered X Ray Imaging Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe AI-powered X Ray Imaging Sales Value (2021-2032)
- 6.4.2 Europe AI-powered X Ray Imaging Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific AI-powered X Ray Imaging Sales Value (2021-2032)
- 6.5.2 Asia-Pacific AI-powered X Ray Imaging Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America AI-powered X Ray Imaging Sales Value (2021-2032)
- 6.6.2 South America AI-powered X Ray Imaging Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa AI-powered X Ray Imaging Sales Value (2021-2032)
- 6.7.2 Middle East & Africa AI-powered X Ray Imaging Sales Value Share by Country, 2025 VS 2032
7 AI-powered X Ray Imaging Country-level Value Analysis
- 7.1 Global AI-powered X Ray Imaging Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global AI-powered X Ray Imaging Sales Value by Country (2021-2032)
- 7.2.1 Global AI-powered X Ray Imaging Sales Value by Country (2021-2026)
- 7.2.2 Global AI-powered X Ray Imaging Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.3.2 USA AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.7.2 France AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.14.2 China AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.17.2 India AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt AI-powered X Ray Imaging Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt AI-powered X Ray Imaging Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt AI-powered X Ray Imaging Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 GE Healthcare
- 8.1.1 GE Healthcare Company Information
- 8.1.2 GE Healthcare Business Overview
- 8.1.3 GE Healthcare AI-powered X Ray Imaging Revenue and Gross Margin (2021-2026)
- 8.1.4 GE Healthcare AI-powered X Ray Imaging Product Portfolio
- 8.1.5 GE Healthcare Recent Developments
- 8.2 Hologic
- 8.2.1 Hologic Company Information
- 8.2.2 Hologic Business Overview
- 8.2.3 Hologic AI-powered X Ray Imaging Revenue and Gross Margin (2021-2026)
- 8.2.4 Hologic AI-powered X Ray Imaging Product Portfolio
- 8.2.5 Hologic Recent Developments
- 8.3 FUJIFILM Holdings
- 8.3.1 FUJIFILM Holdings Company Information
- 8.3.2 FUJIFILM Holdings Business Overview
- 8.3.3 FUJIFILM Holdings AI-powered X Ray Imaging Revenue and Gross Margin (2021-2026)
- 8.3.4 FUJIFILM Holdings AI-powered X Ray Imaging Product Portfolio
- 8.3.5 FUJIFILM Holdings Recent Developments
- 8.4 Siemens Healthineers AG
- 8.4.1 Siemens Healthineers AG Company Information
- 8.4.2 Siemens Healthineers AG Business Overview
- 8.4.3 Siemens Healthineers AG AI-powered X Ray Imaging Revenue and Gross Margin (2021-2026)
- 8.4.4 Siemens Healthineers AG AI-powered X Ray Imaging Product Portfolio
- 8.4.5 Siemens Healthineers AG Recent Developments
- 8.5 Nuance Communications
- 8.5.1 Nuance Communications Company Information
- 8.5.2 Nuance Communications Business Overview
- 8.5.3 Nuance Communications AI-powered X Ray Imaging Revenue and Gross Margin (2021-2026)
- 8.5.4 Nuance Communications AI-powered X Ray Imaging Product Portfolio
- 8.5.5 Nuance Communications Recent Developments
- 8.6 Lunit
- 8.6.1 Lunit Company Information
- 8.6.2 Lunit Business Overview
- 8.6.3 Lunit AI-powered X Ray Imaging Revenue and Gross Margin (2021-2026)
- 8.6.4 Lunit AI-powered X Ray Imaging Product Portfolio
- 8.6.5 Lunit Recent Developments
- 8.7 Zebra Medical Vision
- 8.7.1 Zebra Medical Vision Company Information
- 8.7.2 Zebra Medical Vision Business Overview
- 8.7.3 Zebra Medical Vision AI-powered X Ray Imaging Revenue and Gross Margin (2021-2026)
- 8.7.4 Zebra Medical Vision AI-powered X Ray Imaging Product Portfolio
- 8.7.5 Zebra Medical Vision Recent Developments
- 8.8 Arterys Inc
- 8.8.1 Arterys Inc Company Information
- 8.8.2 Arterys Inc Business Overview
- 8.8.3 Arterys Inc AI-powered X Ray Imaging Revenue and Gross Margin (2021-2026)
- 8.8.4 Arterys Inc AI-powered X Ray Imaging Product Portfolio
- 8.8.5 Arterys Inc Recent Developments
- 8.9 Qure.ai
- 8.9.1 Qure.ai Company Information
- 8.9.2 Qure.ai Business Overview
- 8.9.3 Qure.ai AI-powered X Ray Imaging Revenue and Gross Margin (2021-2026)
- 8.9.4 Qure.ai AI-powered X Ray Imaging Product Portfolio
- 8.9.5 Qure.ai Recent Developments
- 8.10 Agfa-Gevaert Group
- 8.10.1 Agfa-Gevaert Group Company Information
- 8.10.2 Agfa-Gevaert Group Business Overview
- 8.10.3 Agfa-Gevaert Group AI-powered X Ray Imaging Revenue and Gross Margin (2021-2026)
- 8.10.4 Agfa-Gevaert Group AI-powered X Ray Imaging Product Portfolio
- 8.10.5 Agfa-Gevaert Group Recent Developments
- 8.11 Riverain Technologies
- 8.11.1 Riverain Technologies Company Information
- 8.11.2 Riverain Technologies Business Overview
- 8.11.3 Riverain Technologies AI-powered X Ray Imaging Revenue and Gross Margin (2021-2026)
- 8.11.4 Riverain Technologies AI-powered X Ray Imaging Product Portfolio
- 8.11.5 Riverain Technologies Recent Developments
- 8.12 Oxipit
- 8.12.1 Oxipit Company Information
- 8.12.2 Oxipit Business Overview
- 8.12.3 Oxipit AI-powered X Ray Imaging Revenue and Gross Margin (2021-2026)
- 8.12.4 Oxipit AI-powered X Ray Imaging Product Portfolio
- 8.12.5 Oxipit Recent Developments
- 8.13 DeepTek Medical Imaging Private Limited.
- 8.13.1 DeepTek Medical Imaging Private Limited. Company Information
- 8.13.2 DeepTek Medical Imaging Private Limited. Business Overview
- 8.13.3 DeepTek Medical Imaging Private Limited. AI-powered X Ray Imaging Revenue and Gross Margin (2021-2026)
- 8.13.4 DeepTek Medical Imaging Private Limited. AI-powered X Ray Imaging Product Portfolio
- 8.13.5 DeepTek Medical Imaging Private Limited. Recent Developments
- 8.14 ICAD Inc
- 8.14.1 ICAD Inc Company Information
- 8.14.2 ICAD Inc Business Overview
- 8.14.3 ICAD Inc AI-powered X Ray Imaging Revenue and Gross Margin (2021-2026)
- 8.14.4 ICAD Inc AI-powered X Ray Imaging Product Portfolio
- 8.14.5 ICAD Inc Recent Developments
- 8.15 Behold.ai Technologies
- 8.15.1 Behold.ai Technologies Company Information
- 8.15.2 Behold.ai Technologies Business Overview
- 8.15.3 Behold.ai Technologies AI-powered X Ray Imaging Revenue and Gross Margin (2021-2026)
- 8.15.4 Behold.ai Technologies AI-powered X Ray Imaging Product Portfolio
- 8.15.5 Behold.ai Technologies Recent Developments
- 8.16 Imagen Technologies
- 8.16.1 Imagen Technologies Company Information
- 8.16.2 Imagen Technologies Business Overview
- 8.16.3 Imagen Technologies AI-powered X Ray Imaging Revenue and Gross Margin (2021-2026)
- 8.16.4 Imagen Technologies AI-powered X Ray Imaging Product Portfolio
- 8.16.5 Imagen Technologies Recent Developments
- 8.17 VUNO
- 8.17.1 VUNO Company Information
- 8.17.2 VUNO Business Overview
- 8.17.3 VUNO AI-powered X Ray Imaging Revenue and Gross Margin (2021-2026)
- 8.17.4 VUNO AI-powered X Ray Imaging Product Portfolio
- 8.17.5 VUNO Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst